Robert M. Califf - Concepedia

Author

Robert M. Califf

Duke Medical Center

Also Known As

ROBERT M. CALIFF, Robert M. Califf

Publications

Citations

H-Index

Concepts

All Affiliations

Duke Medical Center Duke University Hospital Cleveland Clinic

About

Robert M. Califf is an author at Duke Medical Center specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.5K
2	Emergency Medicine	6	6	921
3	Public Health	1	1	72
4	Cardiothoracic Surgery	1	1	35
5	Epidemiology	1	1	72

Robert M. Califf

Publications

Citations

H-Index

Page 1

	Year	Citations
A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST) Robert M. Califf, Kirkwood F. Adams, William J. McKenna, American Heart Journal Heart FailureEpoprostenol TherapyStructural Heart DiseaseCardiovascular DiseaseControlled Trial	1997	654
Racial Variation in the Use of Coronary-Revascularization Procedures — Are the Differences Real? Do They Matter? Eric D. Peterson, Linda K. Shaw, Elizabeth R. DeLong, New England Journal of Medicine	1997	552
The Evolution of Medical and Surgical Therapy for Coronary Artery Disease Robert M. Califf JAMA Heart FailureImproved SurvivalSurgeryCoronary Artery DiseaseAcute Myocardial Infarction	1989	301
Evidence for Prevention of Death and Myocardial Infarction With Platelet Membrane Glycoprotein IIb/IIIa Receptor Blockade by Abciximab (c7E3 Fab) Among Patients With Unstable Angina Undergoing Percutaneous Coronary Revascularization fn1fn1This study was supported by Centocor, Inc., Malvern, Pennsylvania. A. Michael Lincoff, Robert M. Califf, Keaven M. Anderson, Journal of the American College of Cardiology C7e3 FabPercutaneous Coronary InterventionThrombosisCardiovascular DiseasePharmacology	1997	207
Age and outcome after acute coronary syndromes without persistent ST-segment elevation David Hasdai, David R. Holmes, Douglas A. Criger, American Heart Journal Cardiovascular DiseaseAtherosclerosisPersistent St-segment ElevationAcute Myocardial InfarctionPublic Health	2000	72
Adoption of thrombolytic therapy in the management of acute myocardial infarction Mark A. Hlatky, Harry E. Cotugno, Christopher M. O’Connor, The American Journal of Cardiology ThrombosisCardiovascular DiseaseThrombolytic TherapyPharmacotherapyMedicine	1988	67
Increased Risk of Non-Q Wave Myocardial Infarction After Directional Atherectomy Is Platelet Dependent: Evidence From the EPIC Trial Jeffrey Lefkovits, JAMES C. BLANKENSHIP, KEAVEN M. ERSON, Journal of the American College of Cardiology ThrombosisEpic TrialCardiovascular DiseaseCoronary Artery DiseaseVascular Surgery	1996	57
Glycoprotein IIb/IIIa blockade and thrombolytics: Early lessons from the SPEED and GUSTO IV trials Robert M. Califf American Heart Journal ThrombosisVenous ThrombosisGlycoprotein Iib/iiia BlockadeMedicineHematology	1999	39
Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy Marc Cohen, Sandra S. Stinnett, Beth Davison Weatherley, American Heart Journal ThrombosisCardiovascular DiseaseAtherosclerosisAnticoagulantAcute Myocardial Infarction	2000	36
Clinical Characteristics and Current Management of Medically Refractory Unstable Angina J S Rankin, Joseph Newton, Robert M. Califf, Annals of Surgery Percutaneous Coronary InterventionHypertensionCardiac SurgeryCardiothoracic SurgeryCardiovascular Disease	1984	35

Page 1